Biologics APIs

May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 16, 2018
By Pharmaceutical Technology Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
May 15, 2018
Pharmaceutical Technology
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 14, 2018
By Pharmaceutical Technology Editors
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
Apr 20, 2018
By Pharmaceutical Technology Editors
The new platform is expected to speed up cell line development.
Apr 19, 2018
By Pharmaceutical Technology Editors
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
Apr 19, 2018
By Pharmaceutical Technology Editors
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
Apr 17, 2018
By Pharmaceutical Technology Editors
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
Apr 16, 2018
By Pharmaceutical Technology Editors
Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology.
Apr 12, 2018
By Pharmaceutical Technology Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
native1_300x100
lorem ipsum